首页> 外国专利> A method for determining criteria for the development of early hypercoagulable state in the treatment of patients with acute leukemia

A method for determining criteria for the development of early hypercoagulable state in the treatment of patients with acute leukemia

机译:确定急性白血病患者早期高凝状态发展标准的方法

摘要

FIELD: medicine. SUBSTANCE: method involves determining soluble fibrin monomer complexes, D-dimers in blood and fibrinogen, prothrombin index, ethanol test fibrinogen-fibrin degradation products, plasminogen values, Hagemann-dependent euglobulin lysis time and blood platelets number. Fibrinogen level being 4,21±0,2 g/l, prothrombin index being 91,9±1,3% as high, soluble fibrin monomer complexes in orthophenantrolin one being 188,0±13,9 mcg/l and ethanol test fibrinogenfibrin degradation products level being equal to 1-2 conditional units, D-dimers being higher than 500 mg/ml, plasminogen being available in the amount of 123,0±8,9%, Hagemann- dependent euglobulin lysis time being equal to 27±4,2 min and blood platelets number in blood being equal to 128±19,7•109/l, pre-DIC stage is to be diagnosed. EFFECT: high accuracy of diagnosis. 3 tbl
机译:领域:医学。实质:该方法涉及确定可溶性纤维蛋白单体复合物,血液和纤维蛋白原中的D-二聚体,凝血酶原指数,乙醇测试纤维蛋白原-纤维蛋白降解产物,纤溶酶原值,Hagemann依赖的球蛋白裂解时间和血小板数。纤维蛋白原水平为4,21≥0.2g / l,凝血酶原指数为91,9≥1.3%,原酚酞中的高可溶性纤维蛋白单体复合物为188,0 plusmn; 13.9 mcg / l和乙醇测试的纤维蛋白原纤维蛋白降解产物水平等于1-2个条件单位,D-二聚体高于500 mg / ml,纤溶酶原的可用量为123,0加%; 8.9%,哈格曼依赖性球蛋白的裂解时间等于27加倍。 4,2 min,血液中血小板数等于128±19,7• 10 9 / l,诊断为DIC前期。效果:诊断准确性高。 3汤匙

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号